A monoclonal antibody against mutated nucleophosmin 1 for the molecular diagnosis of acute myeloid leukemias

Blood

Volumn 116, Issue 12, 2010, Pages 2096-2102

  Gruszka, Alicja M ^a   Lavorgna, Serena ^b,c   Consalvo, Maria Irno ^b,c   Ottone, Tiziana ^b,c   Martinelli, Chiara ^a   Cinquanta, Mario ^d   Ossolengo, Giuseppe ^d   Pruneri, Giancarlo ^a   Buccisano, Francesco ^b,c   Divona, Mariadomenica ^b,c   Cedrone, Michele ^e   Ammatuna, Emanuele ^b,c   Venditti, Adriano ^b,c   De Marco, Ario ^d   Lo Coco, Francesco ^b,c   Pelicci, Pier Giuseppe ^a,f  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^d FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^e SAN GIOVANNI ADDOLORATA HOSPITAL   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY T26; NUCLEOPHOSMIN; UNCLASSIFIED DRUG; MUTANT PROTEIN; NUCLEAR PROTEIN; PEPTIDE FRAGMENT;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ANTIBODY SPECIFICITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; WILD TYPE; DIAGNOSTIC USE; GENETICS; IMMUNOLOGY; LEUKEMIA, MYELOID, ACUTE; MOLECULAR DIAGNOSIS; MUTATION;

ANTIBODIES, MONOCLONAL; HUMANS; LEUKEMIA, MYELOID, ACUTE; MOLECULAR DIAGNOSTIC TECHNIQUES; MUTANT PROTEINS; MUTATION; NUCLEAR PROTEINS; PEPTIDE FRAGMENTS;

EID: 77957192466     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-01-266908     Document Type: Article

References (23)

1. Okuwaki M. The structure and functions of NPM1/Nucleophsmin/B23, a multifunctional nucleolar acidic protein. J Biochem. 2008;143(4):441-448. (Pubitemid 351451762)
2. Falini B, Mecucci C, Tiacci E, et al. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med. 2005;352(3):254-266. (Pubitemid 40110814)
3. + AML): biologic and clinical features. Blood. 2007;109(3):874-885.
4. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Vol. 2. Lyon, France: International Agency for Research on Cancer; 2008.
5. + AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem-cell maintenance. Blood. 2005;106(3):899-902.
6. Garzon R, Garofalo M, Martelli MP, et al. Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc Natl Acad Sci U S A. 2008;105(10):3945-3950.
7. Dohner H, Estey EH, Amadori S, et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood. 2010;115(3):453-474.
8. Cilloni D, Messa F, Rosso V, et al. Increase sensitivity to chemotherapeutical agents and cytoplasmatic interaction between NPM leukemic mutant and NF-kappaB in AML carrying NPM1 mutations. Leukemia. 2008;22(6):1234-1240.
9. Falini B, Sportoletti P, Martelli MP. Acute myeloid leukemia with mutated NPM1: diagnosis, prognosis and therapeutic perspectives. Curr Opin Oncol. 2009;21(6):573-581.
10. Ammatuna E, Noguera NI, Zangrilli D, et al. Rapid detection of nucleophosmin (NPM1) mutations in acute myeloid leukemia by denaturing HPLC. Clin Chem. 2005;51(11):2165-2167. (Pubitemid 41532637)
11. Noguera NI, Ammatuna E, Zangrilli D, et al. Simultaneous detection of NPM1 and FLT3-ITD mutations by capillary electrophoresis in acute myeloid leukemia. Leukemia. 2005;19(8):1479-1482.
12. Calvo KL, Ojeda MJ, Ammatuna E, et al. Detection of the nucleophosmin gene mutations in acute myelogenous leukemia through RT-PCR and polyacrylamide gel electrophoresis. Eur J Haematol. 2009;82(1):69-72.
13. Dvorakova D, Lengerova M, Pospisilova J, Palasek I, Mayer J. A novel quantitative assessment of minimal residual disease in patients with acute myeloid leukemia carrying NPM1 (nucleophosmin) exon 12 mutations. Leukemia. 2009;23(4):793-796.
14. Huang Q, Chen W, Gaal KK, Slovak ML, Stein A, Weiss LM. A rapid, one step assay for simultaneous detection of FLT3/ITD and NPM1 mutations in AML with normal cytogenetics. Br J Haematol. 2008;142(3):489-492. (Pubitemid 351962181)
15. Laughlin TS, Becker MW, Liesveld JL, et al. Rapid method for detection of mutations in the nucleophosmin gene in acute myeloid leukemia. J Mol Diagn. 2008;10(4):338-345. (Pubitemid 352019120)
16. Ottone T, Ammatuna E, Lavorgna S, et al. An allele-specific rt-PCR assay to detect type A mutation of the nucleophosmin-1 gene in acute myeloid leukemia. J Mol Diagn. 2008;10(3):212-216.
17. Szankasi P, Jama M, Bahler DW. A new DNA-based test for detection of nucleophosmin exon 12 mutations by capillary electrophoresis. J Mol Diagn. 2008;10(3):236-241.
18. Wertheim G, Bagg A. Nucleophosmin (NPM1) mutations in acute myeloid leukemia: an ongoing (cytoplasmic) tale of dueling mutations and duality of molecular genetic testing methodologies. J Mol Diagn. 2008;10(3):198-202.
19. Falini B, Martelli MP, Bolli N, et al. Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia. Blood. 2006;108(6):1999-2005. (Pubitemid 44395013)
20. Mattsson G, Turner SH, Cordell J, et al. Can cytoplasmic nucleophosmin be detected by immunocytochemical staining of cell smears in acute myeloid leukemia? Haematologica. 2010;95(4):670-673.
21. Cordell JL, Pulford KA, Bigerna B, et al. Detection of normal and chimeric nucleophosmin in human cells. Blood. 1999;93(2):632-642. (Pubitemid 29035746)
22. Colombo E, Martinelli P, Zamponi R, et al. Delocalization and destabilization of the Arf tumor suppressor by the leukemia-associated NPM mutant. Cancer Res. 2006;66(6):3044-3050.
23. Shook D, Coustan-Smith E, Ribeiro RC, Rubnitz JE, Campana D. Minimal residual disease quantitation in acute myeloid leukemia. Clin Lymphoma Myeloma. 2009;9[suppl 3]:S281-S285.